Sabina Abbasova, DPM
Foot & Ankle Surgery · Orangeburg, SCNPI 1174901425
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,921 of the $5,146 with a category attached, or 76.2%. 23 manufacturers reported payments, led by Peerless Surgical Inc. at 25.3% of the total. Reporting peaked in 2021 at $1,316 and has fallen 56.4% since, to $574 in 2025.
Across 74 payments — averaging $69.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Peerless Surgical Inc.$1K
- Kerecis Limited$1K
- Celularity Inc.$385
- Averitas Pharma Inc.$281
- Stryker$230
- Kowa Pharmaceuticals America, Inc.$230
- plus $1K from 17 others
What the payments were for
- Travel & lodging$250%
- Food & beverage$3,92176%
- Education$1,20023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Peerless Surgical Inc. | 5 | $1,302 |
| Kerecis Limited | 5 | $1,276 |
| Celularity Inc. | 3 | $385 |
| Averitas Pharma Inc. | 7 | $281 |
| Stryker | 3 | $230 |
| Kowa Pharmaceuticals America, Inc. | 21 | $230 |
| Fusion Orthopedics USA, LLC | 2 | $171 |
| Triad Life Sciences Inc. | 2 | $169 |
| Convatec Inc. | 2 | $158 |
| Smith+Nephew | 2 | $150 |
| AbbVie | 2 | $144 |
| Stability Biologics, LLC | 1 | $128 |
| Kuros Biosciences USA, Inc | 2 | $104 |
| Organogenesis Inc. | 2 | $91 |
| Paratek Pharmaceuticals, Inc. | 4 | $82 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $78 |
| Amgen(2 entities) | 2 | $60 |
| GRT US Holding, Inc. | 2 | $31 |
| Acera Surgical, Inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
| Paragon 28, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,146 in reported general payments places this provider in the 60th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 146 | $3,483 |
| Ketoconazole | 177 | $2,195 |
| Mupirocin | 105 | $867 |
| Gabapentin | 83 | $657 |
| Ammonium Lactate | 25 | $387 |
| Cephalexin | 17 | $184 |
| Ibuprofen | 17 | $165 |
| Methylprednisolone | 21 | $129 |
| Triamcinolone Acetonide | 25 | $93 |
| Meloxicam | 31 | $57 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Orangeburg
- Kevin RayOrangeburg$7K
- Courtney BordenkecherOrangeburg$5K
- Ibn AnsariOrangeburg$4K
- Christine RihnOrangeburg$2K
- Benjamin OverleyHilton Head Island$643K
- Tyler GonzalezColumbia$525K
- Alison GartenRock Hill$419K
- Christopher GrossCharleston$394K
- Robert KleinGreenville$358K
- William JamesColumbia$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.